Luazon, Anecito P.
HRN: 23-40-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
METRONIDAZOLE 500MG (TAB)
03/03/2026
03/16/2026
ORAL
500mg
BID
H.pylori
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: